Literature DB >> 19828259

Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward.

Christoph von der Goltz1, Anne Koopmann, Christina Dinter, Anne Richter, Christine Rockenbach, Martin Grosshans, Helmut Nakovics, Klaus Wiedemann, Karl Mann, Georg Winterer, Falk Kiefer.   

Abstract

OBJECTIVE: Preclinical data suggest modulating effects of both orexin/hypocretin and leptin on dopaminergic transmission in mesolimbic reward pathways. This indicates a possible role of both peptides in reward function and motivation, and thus in addictive diseases. The aim of this study was to examine the possible association between orexin and leptin, and nicotine craving in smokers in a clinical case-control study under standardized conditions.
METHODS: We compared orexin and leptin, ACTH and cortisol plasma concentrations (RIA) between tobacco smokers (n=60) during early nicotine withdrawal and healthy controls (n=64). Motivational aspects of nicotine craving were additionally assessed in the smoking participants using the Questionnaire of Smoking Urges (QSU).
RESULTS: As main results we detected a significant negative correlation between orexin plasma concentration and nicotine craving (r=-0.28; p<.05), and a positive association between craving and leptin plasma concentration (r=0.29; p<.05).
CONCLUSIONS: Our results show an association between craving for nicotine and plasma concentrations of orexin and leptin suggesting that both peptides interfere with the dopaminergic transmission during nicotine withdrawal in a bidirectional manner and, thus, modulate craving for nicotine. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828259     DOI: 10.1016/j.psyneuen.2009.09.005

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  30 in total

Review 1.  Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses.

Authors:  A C Reichelt; R F Westbrook; M J Morris
Journal:  Br J Pharmacol       Date:  2015-11-01       Impact factor: 8.739

2.  Circulating leptin and pain perception among tobacco-dependent individuals.

Authors:  Mustafa al'Absi; Andrine Lemieux; Motohiro Nakajima; Dorothy K Hatsukami; Sharon Allen
Journal:  Biol Psychol       Date:  2015-02-23       Impact factor: 3.251

3.  Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse.

Authors:  Andrine Lemieux; Motohiro Nakajima; Dorothy K Hatsukami; Sharon Allen; Mustafa al'Absi
Journal:  Psychopharmacology (Berl)       Date:  2015-07-10       Impact factor: 4.530

Review 4.  [What can addiction research contribute towards the understanding of obesity?].

Authors:  F Kiefer; M Grosshans
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

5.  Changes in circulating leptin levels during acute stress and associations with craving in abstinent smokers: a preliminary investigation.

Authors:  Sheena Potretzke; Motohiro Nakajima; Tiffany Cragin; Mustafa al'Absi
Journal:  Psychoneuroendocrinology       Date:  2014-05-23       Impact factor: 4.905

Review 6.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

7.  Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; James S Hodges; Sharon Allen
Journal:  Addict Biol       Date:  2018-08-16       Impact factor: 4.280

Review 8.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 9.  The hypocretin/orexin system: implications for drug reward and relapse.

Authors:  Ainhoa Plaza-Zabala; Rafael Maldonado; Fernando Berrendero
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

Review 10.  The dopamine motive system: implications for drug and food addiction.

Authors:  Nora D Volkow; Roy A Wise; Ruben Baler
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.